Rhumbline Advisers »

Black Diamond Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $213k 49k 4.35
2024-06-30 $218k 47k 4.66
2024-03-31 $2.3k 449 5.07
2023-12-31 $1.3k 449 2.81
2023-09-30 $1.3k 449 2.87
2023-06-30 $2.3k 449 5.05
2022-03-31 $81k 29k 2.79
2021-12-31 $164k 31k 5.32
2021-09-30 $266k 31k 8.47
2021-06-30 $370k 30k 12.20
2021-03-31 $444k 18k 24.25
2020-12-31 $622k 19k 32.04
2020-09-30 $514k 17k 30.20
2020-06-30 $638k 15k 42.14
2020-03-31 $301k 12k 24.96